ctrl K

Watchlist Price Alert

TScan Therapeutics Inc. (TCRX)

NASDAQ: TCRX · Real-Time Price · USD

1.55

0.02 (1.31%)

At close: Jun 17, 2025, 3:59 PM

1.54

-0.65%

After-hours: Jun 17, 2025, 04:04 PM EDT

TScan Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	178.69M	133.36M	120.03M	161.41M	34.79M	41.76M
Short-Term Investments	111.42M	58.69M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	5.04M	5.2M	761K	595K
Other Long-Term Assets	6.8M	6.68M	4.83M	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.61M	2.19M	4.1M	4.25M	n/a	n/a
Total Current Assets	292.72M	194.24M	120.03M	165.65M	36.45M	42.38M
Property-Plant & Equipment	71.6M	71.23M	69.2M	17.26M	12.53M	6.41M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	78.4M	77.91M	79.06M	22.45M	13.29M	7M
Total Assets	371.12M	272.15M	199.09M	188.11M	49.74M	49.38M
Account Payables	4.28M	2.37M	2.91M	1.76M	2.91M	1.01M
Deferred Revenue	11.7M	10.14M	3.87M	11.41M	10.63M	912K
Short-Term Debt	4.57M	3.35M	3.68M	1.65M	n/a	n/a
Other Current Liabilities	6.92M	5.9M	1.11M	2.27M	959K	103K
Total Current Liabilities	35.96M	29.82M	17.3M	21.34M	17.45M	2.4M
Long-Term Debt	32.07M	26.7M	29.29M	n/a	-59.68M	n/a
Other Long-Term Liabilities	60.87M	n/a	49K	97K	-59.44M	59.68M
Total Long-Term Liabilities	94.19M	91.46M	82.35M	5.99M	74.75M	64.13M
Total Liabilities	130.15M	121.28M	99.66M	27.33M	92.2M	66.52M
Total Debt	97.38M	92.43M	85.98M	6.04M	7.43M	4.89M
Common Stock	5K	5K	3K	3K	1K	n/a
Retained Earnings	-375.1M	-247.6M	-158.38M	-92.16M	-43.53M	-17.41M
Comprehensive Income	51K	n/a	-0.00	-188.11M	-59.68M	-0.00
Shareholders Equity	240.97M	150.87M	99.43M	160.78M	-42.46M	-17.14M
Total Investments	111.42M	58.69M	5.04M	5.2M	761K	595K